Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP
Clinical trial NCT06079359 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06079359
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-14
- Primary completion
- 2026-01-06
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.